Company intelligence / Profile preview

Vixiar Medical

Annapolis, Maryland, United Statesvixiar.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Vixiar Medical’s lead product Indicor™ has been clinically tested in several hundred patients against invasive gold standard measures for cardiac filling pressure. The system enables non-invasive, rapid assessment of heart failure status at the point of care and supports sub-clinical detection to prevent hospital readmissions. Regulatory approval efforts are ongoing or recently completed for commercial launch

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Physiological Monitoring

Drug pipeline

1 asset

Indicor

Pre-clinical

Indications: Heart failure

Partnerships

Johns Hopkins University (technology licensed for Indicor™)

Beyond the preview

Go deeper on Vixiar Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vixiar Medical.

Explore the full profile